ERVW-1 and breast cancer: Similarly, Bjerrgarden et al. hypothesized a direct role of Syncytin-1 fusogenic activity in breast cancer based on the fact that MCF-7 and MDA-MB-231 cells express Syncytin-1 on the cell surface and hence are able to fuse with endothelial cells presenting hASCT-2 receptor [76].